Spearhead Bio pioneers in native genome engineering, enabling precision agricultural trait integration.
Spearhead Bio has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Spearhead Bio's investors include National Science Foundation, Grit Road Partners, BioSTL, QRM Capital, BioGenerator Ventures.
Spearhead Bio is headquartered in St Louis, United States.
Spearhead Bio pioneers in native genome engineering, enabling precision agricultural trait integration.
Spearhead Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spearhead Bio — Funding & Investors." VCBacked, September 17, 2026, https://www.vcbacked.co/company/spearhead-bio. Accessed November 14, 2026.
VCBacked. (2026). Spearhead Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/spearhead-bio
{{cite web |title=Spearhead Bio — Funding & Investors |url=https://www.vcbacked.co/company/spearhead-bio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Spearhead Bio? Request a listing update